Mesoblast Ltd (MEOBF) 2.8500 $MEOBF TiGenix's Phase 3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mesoblast Ltd (MEOBF) 2.8500 $MEOBF

TiGenix's Phase 3 Trial Of Allogeneic Stem Cells Is Likely To Succeed
Logribel Biostocks - at Seeking Alpha - Wed May 13, 8:44AM CDT

PFE: 34.36 (+0.50), OSIR: 19.31 (+0.65), GSK: 42.45 (+0.65), ATHX: 1.14 (-0.01), CUR: 1.69 (-0.01)

Repairs To The Heart: The Needle Or The Knife?
Keith Williams - at Seeking Alpha - Mon May 04, 11:37AM CDT

SSH: 3.40 (+0.15), NBS: 2.25 (-0.09), CLDN: 1.26 (+0.01)

Seeking Alpha's Biotech Weekly: Celgene Check-Up, Is Gilead The New Apple?, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 17, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors geared up for earnings season, highlighted several...
SGYP: 9.13 (+0.49), BIIB: 388.23 (-11.06), ARWR: 6.68 (+0.07), AMGN: 154.10 (+2.79), MYL: 71.22 (+0.87), BMY: 69.27 (+1.38), CNCE: 15.71 (+0.27), CELG: 118.84 (+1.97), ATNM: 2.41 (+0.18), PFS: 19.19 (+0.20), NVIV: 14.01 (-1.01), GILD: 113.74 (+0.38), FWP: 39.47 (+1.55), GWPH: 125.86 (+5.39), IBM: 166.95 (+3.10), BAX: 37.61 (+0.59), AZN: 66.45 (+1.90), TEVA: 61.38 (-0.75)

Celgene's Play In Cell-Based Therapy/Regenerative Medicine Is Very Good News For Mesoblast
Keith Williams - at Seeking Alpha - Mon Apr 13, 1:26PM CDT

CELG: 118.84 (+1.97)

Why Investors Shouldn't Worry About Explosive New Drug Pricing: Maxim's Jason Kolbert
Life Sciences Report - Seeking Alpha - Thu Apr 09, 4:59PM CDT
It's the daring Phase 2-stage molecules of today that will bring patients a generation of biotech drugs that could cure certain deadly diseases tomorrow. The candidates that succeed will also energize the portfolios of investors who have exercised...
PSTI: 2.40 (+0.03), NBS: 2.25 (-0.09), OSIR: 19.31 (+0.65), BCLI: 3.46 (-0.03), MDVN: 106.81 (-2.19), INO: 7.46 (+0.19), CYTX: 0.47 (+0.01), STEM: 0.52 (+0.01), JUNO: 52.05 (+1.72), ATHX: 1.14 (-0.01), CUR: 1.69 (-0.01), BLUE: 159.03 (+0.60), VRTX: 122.95 (+2.06), AMGN: 154.10 (+2.79), KERX: 9.81 (+0.11), OMER: 17.33 (+0.29), KITE: 64.36 (+1.05), GILD: 113.74 (+0.38), MRK: 57.95 (+0.57), TEVA: 61.38 (-0.75)

TiGenix: A Deeply Undervalued Stem Cell Company With Upcoming Catalysts
Logribel Biostocks - Seeking Alpha - Tue Jan 13, 8:59AM CST
TiGenix ( OTC:TGXSF ) -- listed on Euronext Brussels -- is a leading but little known Belgian cell therapy biotech with an advanced adipose-derived allogeneic stem cell product platform in various clinical stages. TiGenix also has a commercialized...
PFE: 34.36 (+0.50), OSIR: 19.31 (+0.65), GSK: 42.45 (+0.65), ATHX: 1.14 (-0.01)

Pluristem's Immunotherapy Could Fast-Track GvHD Studies Under Japanese Legislation
Sharon di Stefano - Seeking Alpha - Mon Jan 05, 11:41AM CST
With data in hand that shows evidence its PLX cell therapy produces an immune response, Pluristem Therapeutics (NASDAQ: PSTI ) enters the exploding area of immunotherapy, or treating disease via manipulation of the human immune system, and joins the...
PSTI: 2.40 (+0.03)

Cell Therapy 2015: With Maturity Comes Promise
Life Sciences Report - Seeking Alpha - Wed Dec 24, 6:41AM CST
A number of new and innovative medical paradigms are being explored by companies in the life sciences sector, with one of the front-runners being cell therapy - a disruptive technology that has, in the past few years, progressed out of preclinical...
KOOL: 0.71 (-0.03), AGEN: 9.17 (+0.31), INO: 7.46 (+0.19), NBS: 2.25 (-0.09), OSIR: 19.31 (+0.65), TEVA: 61.38 (-0.75), ATHX: 1.14 (-0.01)

Athersys Could Benefit Immensely From Japan Reimbursement On Stroke
Wall Street Titan - at Seeking Alpha - Wed Nov 26, 7:13AM CST

ATHX: 1.14 (-0.01)

Japan Gives A Hug To The Cell Therapy Industry: R. Lee Buckler
Life Sciences Report - Seeking Alpha - Fri Oct 24, 7:21AM CDT
Last year, Japan rolled out the red carpet for cell therapy developers with new legislation designed to expedite development of regenerative medicine solutions for all manner of disease. In this interview with The Life Sciences Report , former...
PSTI: 2.40 (+0.03), UTHR: 171.57 (+3.88), OSIR: 19.31 (+0.65), ATHX: 1.14 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 4

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading

Top 5 Most Recently Viewed Articles

FGI Industries Reports Strong Q2 2025 Performance Metrics

Updated Category News Views 153

FGI Industries Financial Overview for Q2 2025 FGI Industries Ltd. (Nasdaq: FGI), a prominent supplier of kitchen and bath products, proudly announced its financial results for the second quarter of 2025, reflecting the company’s resilience amidst a challenging economic environment. Key Highlights from Q2 2025 In the second quarter of 2025, FGI reported total revenue of...

Continue Reading
Investigation into Soho House: Ensuring Fair Treatment for Shareholders

Updated Category News Views 158

Soho House Investigation by Ademi Firm The Ademi Firm is actively looking into Soho House & Co Inc. (NYSE: SHCO) concerning potential breaches of fiduciary duty related to its recent transaction to go private. This inquiry is essential to ensure that all public shareholders receive fair treatment as the company makes significant changes in its ownership structure. Details...

Continue Reading
Warren Buffett's Strategic Financial Moves and Stock Gains

Updated Category News Views 374

The Financial Journey of Warren Buffett Warren Buffett, the renowned investor, continues to showcase how strategic investments can yield impressive returns. His company, Berkshire Hathaway Inc (NYSE: BRK), has a significant presence in the financial sector, underscoring the potential of banking stocks. Buffett's Financial Investments Among the noteworthy investments in...

Continue Reading
AGAPE ATP Corporation Announces Reverse Stock Split

Updated Category News Views 61

AGAPE ATP Corporation Announces Reverse Stock Split AGAPE ATP Corporation (NASDAQ: ATPC) has filed a Certificate of Change with the Secretary of State of Nevada to implement a 1-for-20 reverse stock split of its common stock. This change will take effect on August 30, and the Company has shared the details in its filings with the Securities and Exchange Commission. After...

Continue Reading
Water System Partnerships: Community Impact and Insights

Updated Category News Views 8

Digging into Water System Partnerships Crack open a fresh perspective on municipal water system partnerships, courtesy of American Water's latest white paper. This isn't just a PR spiel—it's a deep dive into how these regulated systems can flip the script for resource-strapped municipalities, helping them tackle infrastructure headaches with some actual financial elbow...

Continue Reading